The Epidemiology and Prevention of Donor-Derived Infections

Ahn, 2008, Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation, Liver Transpl, 14, 1603, 10.1002/lt.21534 Bowen PA, 2nd, Lobel SA, Caruana RJ, et al: Transmission of human immunodeficiency virus (HIV) by transplantation: Clinical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med 108:46-48, 2988. Calabrese, 1998, HIV infection in the first heart transplantation in Italy: fatal outcome. Case report, APMIS, 106, 470, 10.1111/j.1699-0463.1998.tb01373.x Fischer, 2006, Transmission of lymphocytic choriomeningitis virus by organ transplantation, N Engl J Med, 354, 2235, 10.1056/NEJMoa053240 Iwamoto, 2003, Transmission of West Nile Virus from an organ donor to four transplant recipients, N Engl J Med, 348, 2196, 10.1056/NEJMoa022987 Limaye, 2000, Transmission of histoplasma capsulatum by organ transplantation, N Engl J Med, 343, 1163, 10.1056/NEJM200010193431605 Lumbreras, 2001, Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients, Clin Infect Dis, 33, 722, 10.1086/322599 Palacios, 2008, A new arenavirus in a cluster of fatal transplant-associated diseases, N Engl J Med, 358, 991, 10.1056/NEJMoa073785 Srinivasan, 2005, Transmission of rabies virus from an organ donor to four transplant recipients, N Engl J Med, 352, 1103, 10.1056/NEJMoa043018 Avery, 2002, Recipient screening prior to solid-organ transplantation, Clin Infect Dis, 35, 1513, 10.1086/344777 2004, Screening of donor and recipient prior to solid organ transplantation, Am J Transplant, 4, 10, 10.1111/j.1600-6135.2004.00616.x Ali, 1998, Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation, Transplantation, 66, 1694, 10.1097/00007890-199812270-00021 Gasink, 2006, Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients, JAMA, 296, 1843, 10.1001/jama.296.15.1843 Chung, 2001, Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor, Am J Transplant, 1, 185, 10.1034/j.1600-6143.2001.10214.x de Villa, 2003, Hepatitis B core antibody-positive grafts: recipient's risk, Transplantation, 75, S49, 10.1097/01.TP.0000047006.96782.64 Hodson, 2008, Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients, Cochrane Database Syst Rev CD003774(2), 10.1002/14651858.CD003774.pub3 Sun, 2008, Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: A systematic review, Am J Transplant, 8, 2111, 10.1111/j.1600-6143.2008.02369.x Souza, 2008, Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: A case report, Transplant Proc, 40, 875, 10.1016/j.transproceed.2008.02.032 2006, Chagas disease after organ transplantation—Los Angeles, California, 2006, MMWR Morb Mortal Wkly Rep, 55, 798 2002, Chagas disease after organ transplantation—United States, 2001, MMWR Morb Mortal Wkly Rep, 51, 210 2008, Transplantation-transmitted tuberculosis—Oklahoma and Texas, 2007, MMWR Morb Mortal Wkly Rep, 57, 333 Graham, 2001, Tuberculosis transmitted through transplantation, J Infect, 43, 251, 10.1053/jinf.2000.0879 Peters, 1984, Transmission of tuberculosis by kidney transplantation, Transplantation, 38, 514, 10.1097/00007890-198411000-00015 Winthrop, 2004, Transmission of mycobacterium tuberculosis via lung transplantation, Am J Transplant, 4, 1529, 10.1111/j.1600-6143.2004.00536.x 2005, West Nile virus infections in organ transplant recipients—New York and Pennsylvania, August-September, 2005, MMWR Morb Mortal Wkly Rep, 54, 1021 The National Organ Transplant Act. 42 U.S.C. §273 et seq. (1987) The OPTN Final Rule. 42 CFR, part 121 et seq. OPTN Policy 2.2. Available at: http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_2.pdf. Accessed May 25, 2009 OPTN Policy 4. Available at: http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_16.pdf. Accessed May 25, 2009 1994, Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs, MMWR Morb Mortal Wkly Rep, 43, 1 Conditions for Coverage and Conditions for Participations: Organ Procurement Organizations. Centers for Medicare and Medicaid Studies. 2 CFR Parts §§486.301–348. Available at: http://www.cms.hhs.gov/CFCsAndCoPs/08_OPOs.asp#TopOfPage. Accessed May 25, 2009 Conditions for Coverage and Conditions for Participations: Transplant Center. Centers for Medicare and Medicaid Studies. 42 FR §482.68-§482.104. Available at: http://www.cms.hhs.gov/CFCsAndCoPs/11_transplantcenter.asp#TopOfPage. Accessed May 25, 2009 Lumbreras C: Bacterial pathogens and donor transmission. 3rd International Transplant Infectious Diseases Conference. Prague, Czech Republic, September 29-30, 2007 Kiberd, 2004, Screening for West Nile Virus in organ transplantation: a medical decision analysis, Am J Transplant, 4, 1296, 10.1111/j.1600-6143.2004.00519.x Dodd, 2002, Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population, Transfusion, 42, 975, 10.1046/j.1537-2995.2002.00174.x 1987, Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody—North Carolina, MMWR Morb Mortal Wkly Rep, 36, 306 Kucirka, 2009, Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs, Am J Transplant, 9, 620, 10.1111/j.1600-6143.2008.02522.x Kucirka, 2009, Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs, Am J Transplant, 9, 629, 10.1111/j.1600-6143.2008.02523.x Fishman JA, Strong DM, Kuehnert MJ: Organ and tissue safety workshop 2007: advances and challenges. Cell Tissue Bank, November 19, 2008